BRIEF published on 02/18/2026 at 07:25, 2 months 27 days ago Dexus Adjusts Exchange Price for A$500 Million Notes Investment Exchangeable Notes Dexus 2027 Price Adjustment
BRIEF published on 02/18/2026 at 07:25, 2 months 27 days ago Dexus ajuste le prix de change de ses obligations d'une valeur de 500 millions de dollars australiens Investissement Dexus Billets Échangeables 2027 Ajustement De Prix
BRIEF published on 02/18/2026 at 07:20, 2 months 27 days ago Intershop Reports 2025 Financial Results with Revenue Decline Operating Loss Intershop 2026 Outlook Financial Results 2025 Cloud Revenue Stability
BRIEF published on 02/18/2026 at 07:20, 2 months 27 days ago Intershop publie ses résultats financiers pour 2025, faisant état d'une baisse de son chiffre d'affaires. Perte D'exploitation Intershop Résultats Financiers 2025 Perspectives 2026 Stabilité Des Revenus Du Cloud
BRIEF published on 02/18/2026 at 07:05, 2 months 27 days ago SAF-HOLLAND SE Reports Solid Profitability Despite Challenging Market in 2025 Market Challenges Profitability SAF-HOLLAND SE 2025 Financial Results Aftermarket Resilience
BRIEF published on 02/18/2026 at 07:05, 2 months 27 days ago SAF-HOLLAND SE annonce une solide rentabilité malgré un marché difficile en 2025 Rentabilité SAF-HOLLAND SE Défis Du Marché Résultats Financiers 2025 Résilience Du Marché De L'après-vente
BRIEF published on 02/18/2026 at 07:05, 2 months 27 days ago Straumann Group Sees Robust Growth in 2025 Straumann Group 2025 Global Revenue Growth Innovation And Digital Solutions Regional Market Performance 2026 Financial Outlook
BRIEF published on 02/18/2026 at 07:05, 2 months 27 days ago Le groupe Straumann prévoit une forte croissance en 2025 Groupe Straumann 2025 Croissance Des Revenus Mondiaux Solutions D'innovation Et Numériques Performance Du Marché Régional Perspectives Financières 2026
BRIEF published on 02/18/2026 at 07:05, 2 months 27 days ago Sandoz Expands Enzeevu® Label with FDA Approval for Retinal Indications FDA Approval Biosimilars Sandoz Enzeevu Retinal Indications
BRIEF published on 02/18/2026 at 07:05, 2 months 27 days ago Sandoz étend l'indication d'Enzeevu® grâce à l'approbation de la FDA pour les affections rétiniennes Approbation De La FDA Biosimilaires Sandoz Enzeevu Indications Rétiniennes
Published on 05/16/2026 at 01:15, 1 day 18 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 20 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 20 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 1 day 4 hours ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 23 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 2 days 1 hour ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days 5 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 5 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 9 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 11 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 2 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
